SCHEMBL6539338

SCHEMBL6539338

CC(C)(C)OC(=O)N(C[C@@H](COc1ccccc1)O[Si](C)(C)C)[C@H](CO[Si](C)(C)C)Cc1ccc(NC(=O)Nc2ccccc2[N+](=O)[O-])cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 6/20 0.39
ADRB3 P13945 6/20 0.39
ADRB2 P07550 1/20 0.39
ABCG2 Q9UNQ0 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
CDK4 P11802 1/20 0.37
CDK2 P24941 1/20 0.37
ABCB1 P08183 2/20 0.36
PDGFRA P16234 1/20 0.36
KDR P35968 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
CXCR1 P25024 1/20 0.34
CXCR2 P25025 1/20 0.34
PPIA P62937 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538684 0.83 ADRB1 (0.44) ADRB1ADRB3ADRB2NPC1RAB9A
SCHEMBL6539708 0.81 ADRB3 (0.36) ADRB3
SCHEMBL6539211 0.80 ADRB1 (0.54) ADRB1ADRB3ADRB2ABCG2ALDH1A1
SCHEMBL6539214 0.80 ADRB1 (0.54) ADRB1ADRB3ADRB2ABCG2ALDH1A1
SCHEMBL6539353 0.77 ADRB1 (0.42) ADRB1ADRB3SMN1; SMN2KDM4EALDH1A1
SCHEMBL6539595 0.75 MAPT (0.48) ADRB1ADRB3ADRB2NPC1RAB9A
SCHEMBL6538469 0.73 MEN1 (0.47) ADRB1ADRB3NPC1RAB9ASMN1; SMN2
SCHEMBL6539067 0.71 ADRB1 (0.49) ADRB1ADRB3ADRB2
SCHEMBL6539522 0.69 ADRB1 (0.52) ADRB1ADRB3ADRB2NPC1RAB9A
SCHEMBL18651963 0.68 ALOX5 (0.36) ADRB3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed